USPTO serial 98648435
ONTELRIQ
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 30, 2025
- Examiner
- KRASS, KRISTINA M
- Law office
- INTENT TO USE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ONTELRIQ?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Boulogne-Billancourt, FR
Paris, FR
Paris, FR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ben Natter
Ben Natter Haug Partners, LLP745 Fifth AvenueNew York, NY 10151United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for treating cancer, oncological diseases, rare diseases, namely, growth disorders, bone diseases, musculoskeletal diseases, namely, fibrodysplasia ossificans progressiva, connective tissue diseases, spinal cord diseases, fractures, sprains, cartilage injuries, rare chronic liver diseases and cholestatic diseases, liver diseases, respiratory diseases, cardiovascular diseases, immune disorders, namely autoimmune diseases, chronic liver diseases, gastrointestinal diseases, metabolic diseases, namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy and anemia, inflammatory diseases, namely, enteric disease and connective tissue inflammation, urological diseases, disorders and diseases of the genitourinary system, namely, infertility, urovaginal infections, bladder disorders and sexually transmitted diseases, diseases and disorders of precocious puberty, gynecological disorders, to stimulate human fertility, for the treatment of acromegaly and malignant tumors, hormonal disorders, endocrine system disorders, namely, growth and thyroid gland disorders, connective tissue diseases, blood disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases, namely, brain injuries, spinal cord injuries, epileptic disorders, Alzheimer's disease, Huntington's disease and cerebral palsy, musculoskeletal disorders, bone diseases, neuromuscular disorders, namely, muscular dystrophy, muscle dystonias and cervical dystonia, cerebral palsy, muscle spasticity, blepharospasm, migraine, for the treatment of pain, for the treatment of glabellar lines, facial wrinkles, for the treatment and prevention of skin diseases, facial asymmetry | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 30, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 30, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 28, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 28, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 28, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 28, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Aug 28, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 7, 2025 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| May 7, 2025 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Apr 29, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 4, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 4, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 26, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 11, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 11, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 11, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 11, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 11, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 24, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 24, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 24, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 17, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 17, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 17, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 31, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 15, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 15, 2024 | NWAP | NEW APPLICATION ENTERED | — |